BRCA1 and neoplasm: In GC, BRCA1 deficiency is significantly associated with patients with diffused Lauren type, higher tumor grades, and advanced clinical stage; these patients live significantly shorter than those with positive expression of BRCA1, indicating that loss of BRCA1 can serve as a prognostic marker [145].